Cargando…
Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9
Serum deficiency diseases such as alpha-1-antitrypsin deficiency are characterized by reduced function of serum proteins, caused by deleterious genetic mutations. These diseases are promising targets for genetic interventions. Gene therapies using viral vectors have been used to introduce correct co...
Autores principales: | Stephens, Calvin J., Kashentseva, Elena, Everett, William, Kaliberova, Lyudmila, Curiel, David T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919923/ https://www.ncbi.nlm.nih.gov/pubmed/29588497 http://dx.doi.org/10.1038/s41434-018-0003-1 |
Ejemplares similares
-
Adenoviral targeting using genetically incorporated camelid single variable domains
por: Kaliberov, Sergey A., et al.
Publicado: (2014) -
Transcriptional Targeting of Primary and Metastatic Tumor Neovasculature by an Adenoviral Type 5 Roundabout4 Vector in Mice
por: Lu, Zhi Hong, et al.
Publicado: (2013) -
CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes
por: Ehrke-Schulz, Eric, et al.
Publicado: (2017) -
The myeloid binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting
por: Lu, Zhi Hong, et al.
Publicado: (2014) -
Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components
por: Maggio, Ignazio, et al.
Publicado: (2020)